An unfavourable environment weighs on ANALOGIC CORP., which sees a downgrade to Slightly Negative
The independent financial analyst theScreener just requalified the general evaluation of ANALOGIC CORP. (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date May 25, 2018, the closing price was USD 83.60 and its target price was estimated at USD 73.44.Analogic designs, manufactures, and commercializes real-time guidance, diagnostic imaging and threat detection technologies to practice medicine. The company operates three business segments: Medical Imaging, which provides critical enabling medical imaging systems and subsystems for computed tomography, magnetic resonance imaging and high-resolution digital mammography; Ultrasound, which provides real-time ultrasound procedure guidance systems for the urology, surgery and point of care markets; and Security and Detection, which designs and manufactures automated threat detection systems for aviation baggage inspection applications.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.